Showing 1,201 - 1,220 results of 64,799 for search '(((( “cost OR “post) OR “most) in the shell” ) OR ( “host in the shell” ))~', query time: 0.67s Refine Results
  1. 1201
  2. 1202
  3. 1203
  4. 1204
  5. 1205

    High cost burden and health consequences of antibiotic resistance: the price to pay by Sujith J Chandy, Girish S Naik, Veeraraghavan Balaji, Visalakshi Jeyaseelan, Kurien Thomas, Cecilia Stalsby Lundborg

    Published 2014-09-01
    “…Introduction: Rising antibiotic resistance may negatively affect the health and cost of care for patients. This study aimed to determine the impact of antibiotic resistance on costs and health consequences for patients. …”
    Get full text
    Article
  6. 1206
  7. 1207
  8. 1208

    Intra-articular injections for knee osteoarthritis management: Analysis of cost-effectiveness by Hanna Mass, Jamie E. Collins, Catherine Yang, David J. Hunter, Morgan H. Jones, Love Tsai, Stephen P. Messier, Tuhina Neogi, Jeffrey N. Katz, Elena Losina

    Published 2025-09-01
    “…CS was dominated (more costly, less effective) by saline. If saline was not included, ICER for HA was reduced to $22,400/QALY. …”
    Get full text
    Article
  9. 1209

    An assessment of China’s methane mitigation potential and costs and uncertainties through 2060 by Nina Khanna, Jiang Lin, Xu Liu, Wenjun Wang

    Published 2024-11-01
    “…Here we show the significant cost-effective potential for reducing methane emissions in China by 2030, with 660 million tonnes of carbon dioxide equivalent possible with average negative abatement costs of US$6.40 per tonne CO2e. …”
    Get full text
    Article
  10. 1210

    Multi-Channel Cellytics for Rapid and Cost-Effective Monitoring of Leukocyte Activation by Hojin Cheon, Samir Kumar, Inha Lee, Sanghoon Shin, Hyeji Jang, Young-Sun Lee, Myung-Hyun Nam, Hyun Sik Jun, Sungkyu Seo

    Published 2025-02-01
    “…Here, we present an improved Cellytics system that has been upgraded to a four-channel configuration to achieve higher throughput while maintaining robust reproducibility for rapid and cost-effective leukocyte analysis. The performance of this multi-channel Cellytics system was improved through refinements to the micro-pinhole chip. …”
    Get full text
    Article
  11. 1211
  12. 1212
  13. 1213
  14. 1214

    Evaluation of Treatment Patterns and Direct Costs Associated with the Management of Neuropathic Pain by Manuel E Machado-Duque, Andres Gaviria-Mendoza, Jorge E Machado-Alba, Natalia Castaño

    Published 2020-01-01
    “…The aim was to determine the treatment patterns and direct costs of care associated with the management of neuropathic pain from the onset of the first symptom to up to two years after diagnosis. …”
    Get full text
    Article
  15. 1215

    Lung cancer screening with volume computed tomography is cost-effective in Greece. by Xuanqi Pan, Katerina Togka, Hilde Ten Berge, Lisa de Jong, Harry Groen, Maarten J Postma, Eleftherios Zervas, Ioannis Gkiozos, Christoforos Foroulis, Kyriaki Tavernaraki, Sofia Lampaki, Georgia Kourlaba, Antonios Moraris, Sofia Agelaki, Konstantinos Syrigos

    Published 2025-01-01
    “…Screen-detected lung cancers, costs, life years (LYs), quality-adjusted life years (QALYs), and the incremental cost-effectiveness ratio (ICER) were predicted. …”
    Get full text
    Article
  16. 1216
  17. 1217

    Cost analysis of treating cardiovascular diseases in a super-specialty hospital. by Atul Kumar, Vijaydeep Siddharth, Soubam Iboyaima Singh, Rajiv Narang

    Published 2022-01-01
    “…Traditional Costing and Time Driven Activity Based Costing (TDABC) methods were used for cost computation. …”
    Get full text
    Article
  18. 1218

    Unveiling the Cost-Effectiveness of Chlamydia Screening Strategies: A Systematic Review by Emídio Mata, António Angélico-Gonçalves, Ana Rita Leite, Diogo Queiroz Almeida

    Published 2025-01-01
    “…Summary: This study systematically reviewed EMBASE, PubMed, and SCOPUS databases, from inception to October 2022, Chlamydia infection screening strategies’ cost-effectiveness studies analyzing Incremental Cost Effectiveness Ratio (ICER) of QALYs versus no screening. …”
    Get full text
    Article
  19. 1219
  20. 1220